Merck Healthcare KGaA (manufacturing of finished medicinal product, primary and secondary packaging, labeling, quality control and batch release)

The drug is used to treat metastatic colorectal cancer (provided certain genetic markers are present, such as wild-type RAS genes and EGFR expression) and squamous cell carcinoma of the head and neck (in combination with radiotherapy or chemotherapy, or as monotherapy).

Dosage form: solution for infusion

ATC: L01FE01